CA2308766A1 - Analyse diagnostique permettant de determiner la susceptibilite au cancer - Google Patents

Analyse diagnostique permettant de determiner la susceptibilite au cancer Download PDF

Info

Publication number
CA2308766A1
CA2308766A1 CA002308766A CA2308766A CA2308766A1 CA 2308766 A1 CA2308766 A1 CA 2308766A1 CA 002308766 A CA002308766 A CA 002308766A CA 2308766 A CA2308766 A CA 2308766A CA 2308766 A1 CA2308766 A1 CA 2308766A1
Authority
CA
Canada
Prior art keywords
sequence
diagnostic assay
cancer susceptibility
utr
probability
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002308766A
Other languages
English (en)
Other versions
CA2308766C (fr
Inventor
Eldon R. Jupe
Linda F. Thompson
Regina Resta
Robert T. Dell'orco
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oklahoma Medical Research Foundation
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2308766A1 publication Critical patent/CA2308766A1/fr
Application granted granted Critical
Publication of CA2308766C publication Critical patent/CA2308766C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C12Q1/683—Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA002308766A 1997-11-06 1998-11-06 Analyse diagnostique permettant de determiner la susceptibilite au cancer Expired - Fee Related CA2308766C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6488097P 1997-11-06 1997-11-06
US60/064,880 1997-11-06
PCT/US1998/023686 WO1999024614A1 (fr) 1997-11-06 1998-11-06 Analyse diagnostique permettant de determiner la susceptibilite au cancer

Publications (2)

Publication Number Publication Date
CA2308766A1 true CA2308766A1 (fr) 1999-05-20
CA2308766C CA2308766C (fr) 2007-03-20

Family

ID=22058829

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002308766A Expired - Fee Related CA2308766C (fr) 1997-11-06 1998-11-06 Analyse diagnostique permettant de determiner la susceptibilite au cancer

Country Status (7)

Country Link
US (1) US7094538B2 (fr)
EP (1) EP1038026B1 (fr)
JP (1) JP2002502584A (fr)
AU (1) AU744455B2 (fr)
CA (1) CA2308766C (fr)
DE (1) DE69828647T2 (fr)
WO (1) WO1999024614A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7273855B2 (en) 1999-07-24 2007-09-25 Oklahoma Medical Research Foundation Use of prohibitin RNA in treatment of cancer
US20040029196A1 (en) * 2001-12-31 2004-02-12 Nitin Telang Epithelial cell lines from gene knockout mice and methods of use thereof
US8686152B2 (en) * 2010-03-10 2014-04-01 Janssen Pharmaceutica Nv 4,4-disubstituted piperidine derivatives useful as inhibitors of dipeptidyl peptidase-1 (DPP-1)
US10415094B2 (en) * 2016-10-06 2019-09-17 HelicalHelp LLC Risk stratification method for a patient having a polymorphism

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05271294A (ja) * 1992-01-24 1993-10-19 Japan Found Cancer Res ヒトプロヒビチンおよびそれをコードするｄｎａ
CN1172502A (zh) 1994-08-12 1998-02-04 亿万遗传股份有限公司 17q连锁的乳房癌和卵巢癌易患性基因的体内突变和多态性
US5922852A (en) * 1995-06-07 1999-07-13 Oklahoma Medical Research Foundation 3' untranslated region of the human prohibitin gene
US6355427B1 (en) * 1996-11-07 2002-03-12 Oklahoma Medical Research Foundation Diagnostic assay for breast cancer susceptibility

Also Published As

Publication number Publication date
EP1038026A1 (fr) 2000-09-27
US20030073107A1 (en) 2003-04-17
JP2002502584A (ja) 2002-01-29
DE69828647T2 (de) 2005-12-01
AU744455B2 (en) 2002-02-21
DE69828647D1 (de) 2005-02-17
EP1038026B1 (fr) 2005-01-12
WO1999024614A1 (fr) 1999-05-20
CA2308766C (fr) 2007-03-20
AU1385199A (en) 1999-05-31
US7094538B2 (en) 2006-08-22

Similar Documents

Publication Publication Date Title
FI953445A0 (fi) Menetelmä nukleiinihappojen herkkään osoitukseen
CA2269664A1 (fr) Methode diagnostique pour determiner la predisposition d'un sujet a developper un carcinome mammaire
DE69430665D1 (de) Empfindlicher nukleinsäure-sandwichhybridisierungs-assay und kits
EP0797685A4 (fr) ANALYSE DE L'EXPRESSION DE GENES PAR MISE EN EVIDENCE DE FRAGMENTS DE RESTRICTION DE L'EXTREMITE 3' D'ADNc
NO940744L (fr)
ZA972909B (en) Detecting genetic predisposition for osteoporosis
EP0961833A4 (fr) Hyaluronidase du plasma humain
EP1026262A3 (fr) Des amorces oligonucléotides pour une détection efficace du virus hépatite C (HCV) et des procédés d'usage
WO2002043758A3 (fr) Utilisation de genes et reactifs associes
DE60030145D1 (de) Nachweisverfahren für kurze sequenzvarianten
AU2003226052A8 (en) Methods for detecting abnormally methylated nucleic acid in heterogeneous biological samples
ES2170145T3 (es) Sustancias y procedimientos de deteccion de micobacterium tuberculosis.
WO2001075175A3 (fr) Prediction de susceptibilite cancereuse sur la base du polymorphisme du gene de la superoxyde dismutase a manganese
DK0477972T3 (fr)
IL81695A (en) Quantitative determination of the degree of amplification of genes and/or corresponding messenger rna and reagent kit for performing the determination
WO2004044163A3 (fr) Procedes pour identifier les risques de melanomes et leurs traitements
GB2235769B (en) Detection of inherited disease alleles in DNA samples using yeast artificial chromosomes
ES2175095T3 (es) Marcadores de adn respecto al tamaño de una camada de cerdos.
CA2118724A1 (fr) Methode de detection des genes c-raf-1
CA2308766A1 (fr) Analyse diagnostique permettant de determiner la susceptibilite au cancer
DK0572120T3 (da) Nucleinsyre-probertil mycobacterium tuberculosis
WO2001029262A3 (fr) Reactifs de genotypage, kits et procedes d'utilisation desdits reactifs
NZ328976A (en) Quantitative determination of 1,5-anhydroglucitol using an enzyme (typically trehalase)
WO1999011799A3 (fr) Gene d'aminopeptidase p humaine
WO1997043446A3 (fr) Methode et appareil permettant de diagnostiquer une predisposition a certaines affections, notamment l'osteoporose, sur la base du polymorphisme d'un gene de l'il-6

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed